Rare diseases
Investigational molecules
Locations
Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
AustriaStudy on the Effectiveness of Sirolimus and Trametinib for Treating Diffuse Intrinsic Pontine Glioma in Children Aged 3-18 Years
PolandStudy on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers
NorwayLong-Term Safety Study of Dabrafenib Mesylate and Trametinib Dimethyl Sulfoxide for Patients Benefiting from Previous Treatment in Multiple Indications
AustriaStudy on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer
NorwayStudy on the Effectiveness of Pembrolizumab and Ipilimumab in Melanoma Patients with Brain Metastases Requiring Steroid Treatment
DenmarkStudy of Drug Combination Treatment Based on Tumor Molecular Changes in Patients with Advanced or Metastatic Cancer
FranceStudy of dabrafenib and trametinib combination therapy before and after surgery in patients with BRAF-mutated anaplastic thyroid cancer
The NetherlandsStudy of Drug Combination for Advanced Cancer Patients with Known Molecular Profile - FINPROVE Study
FinlandStudy Comparing Trametinib and Vinblastine for Children and Young Adults with Newly Diagnosed Low-Grade Glioma with Wild-Type BRAF Gene
FranceStudy on the Effectiveness of Entrectinib and Other Drug Combinations for Patients with Advanced Solid Tumors, Multiple Myeloma, or Non-Hodgkin Lymphoma
The NetherlandsStudy on the Safety and Effects of CC-92480 with Dexamethasone and Drug Combinations for Patients with Relapsed or Refractory Multiple Myeloma
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
